Cargando…
TLR3 Activation of Intratumoral CD103(+) Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity
An important challenge in cancer immunotherapy is to expand the number of patients that benefit from immune checkpoint inhibitors (CI), a fact that has been related to the pre-existence of an efficient anti-tumor immune response. Different strategies are being proposed to promote tumor immunity and...
Autores principales: | Roselli, Emiliano, Araya, Paula, Núñez, Nicolás Gonzalo, Gatti, Gerardo, Graziano, Francesca, Sedlik, Christine, Benaroch, Philippe, Piaggio, Eliane, Maccioni, Mariana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6435583/ https://www.ncbi.nlm.nih.gov/pubmed/30949170 http://dx.doi.org/10.3389/fimmu.2019.00503 |
Ejemplares similares
-
Prognostic implications of intratumoral CD103(+) tumor-infiltrating lymphocytes in pulmonary squamous cell carcinoma
por: Koh, Jaemoon, et al.
Publicado: (2017) -
Lymph node invasion by tumor cells modifies the distribution of dendritic cell subsets and memory T cell profiles in human cancer patients
por: Núñez, Nicolás Gonzalo, et al.
Publicado: (2014) -
High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer
por: Gatti, Gerardo, et al.
Publicado: (2021) -
Correction to: High IRF8 expression correlates with CD8 T cell infiltration and is a predictive biomarker of therapy response in ER-negative breast cancer
por: Gatti, Gerardo, et al.
Publicado: (2021) -
Aging Impairs the Ability of Conventional Dendritic Cells to Cross-Prime CD8(+) T Cells upon Stimulation with a TLR7 Ligand
por: Zacca, Estefanía R., et al.
Publicado: (2015)